Reading a preclinical paper: what belongs beside the abstract? · RESEARCH-11763

Put the species or model, design, comparator and measured endpoint before the interpretation. The reader should be able to see what was observed without relying on the headline.

Was the analysis prespecified or exploratory, and how was uncertainty reported? Record what the paper states and mark unreported fields instead of assuming good practice.

Separate the authors’ proposed mechanism from the measurements that support it. A plausible explanation is not automatically a demonstrated pathway.

A human-benefit claim needs appropriate human evidence. This preclinical note should describe its model and translation limits rather than suggesting a treatment change.

The corrected summary can be useful without a clinical promise: model, methods, endpoint, uncertainty and remaining questions. Link each material statement to its source location.

Check the primary paper, supplementary material and any publisher correction. A review article can help locate sources, but it is not a substitute for verifying the cited observation.

Clarification for “Reading a preclinical paper: what belongs beside the abstract?”: the point beginning “Put the species or model, design, comparator and…” belongs to the question as written. It should not be read as a report that a new check, purchase or experiment has been completed. Review focus: scope. Keep the stated question separate from any broader claim.

Method note for “Reading a preclinical paper: what belongs beside the abstract?”: use “Put the species or model, design, comparator and…” as a row heading in a proposed working record. Put the statement, its supporting source or measurement, and any unresolved detail in separate fields. This proposes a format; it supplies no additional evidence. Keep the stated question separate from any broader claim.